Cystic fibrosis is an autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR is expressed in the apical surface of cholangiocytes.30
CFTR gene mutations result in excessive viscous bile secretion secondary to deficient surface fluid and bicarbonate efflux. The viscous bile causes obstruction in the ducts, resulting in hepatotoxicity, which leads to fibrosis and ultimately cirrhosis.30
Cystic fibrosis is the most common genetic disorder among Caucasian children, with estimated incidence ranging from between 1 in 8,000 to 1 in 10,000 individuals.4 Liver complications in these patients are also common, with 25-60% of patients presenting with hepatic steatosis, 15% with cholelithiasis and cholecystitis, and under 10% with neonatal cholestasis, which is the earliest manifestation of liver involvement in cystic fibrosis.30-31 is neonatal cholestasis.
1. Protocole national de diagnostic et de soins : Déficits de synthèse des acides biliaires primaires. Centre de Référence Coordonnateur de l’Atrésie des Voies Biliaires et des Cholestases Génétiques; 2019.
4. Orphanet: The portal for rare diseases and orphan drugs. 2020. at https://www.orpha.net/consor/cgi-bin/Disease.php?lng=EN.)
30. Al Sinani S, Al-Mulaabed S, Al Naamani K, Sultan R. Cystic fibrosis liver disease: know more. Oman Med J 2019;34:482-9.
31. Leeuwen L, Fitzgerald DA, Gaskin KJ. Liver disease in cystic fibrosis. Paediatr Respir Rev 2014;15:69-74.
32. Ross LF. Newborn screening for cystic fibrosis: a lesson in public health disparities. J Pediatr 2008;153:308-13.
33. Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-s14.